Kent Armeson to Carcinoma, Squamous Cell
This is a "connection" page, showing publications Kent Armeson has written about Carcinoma, Squamous Cell.
Connection Strength
0.607
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
Score: 0.135
-
Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma. BMC Cancer. 2020 Mar 17; 20(1):229.
Score: 0.120
-
Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. Am J Otolaryngol. 2019 Jan - Feb; 40(1):40-45.
Score: 0.108
-
Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res. 2017 May; 309(4):243-251.
Score: 0.098
-
Cervical esophageal cancer: a population-based study. Head Neck. 2015 Jun; 37(6):808-14.
Score: 0.081
-
Cetuximab therapy for head and neck squamous cell carcinoma: a systematic review of the data. Otolaryngol Head Neck Surg. 2011 May; 144(5):676-84.
Score: 0.065